179 related articles for article (PubMed ID: 35246508)
1. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma.
Yin DP; Zheng YF; Sun P; Yao MY; Xie LX; Dou XW; Tian Y; Liu JS
Cell Death Dis; 2022 Mar; 13(3):210. PubMed ID: 35246508
[TBL] [Abstract][Full Text] [Related]
2. Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma.
Yin DP; Zhang H; Teng H; Zhang D; Chen P; Xie L; Liu JS
Cell Death Dis; 2023 Dec; 14(12):792. PubMed ID: 38049415
[TBL] [Abstract][Full Text] [Related]
3. p38gamma overexpression promotes renal cell carcinoma cell growth, proliferation and migration.
Chen XF; Pan YS; Zheng B; Lu Q
Biochem Biophys Res Commun; 2019 Aug; 516(2):466-473. PubMed ID: 31229268
[TBL] [Abstract][Full Text] [Related]
4. Targeting p38γ to inhibit human colorectal cancer cell progression.
Su C; Sun Q; Liu S; Wang H; Feng L; Cao Y
Biochem Biophys Res Commun; 2019 Sep; 517(1):172-179. PubMed ID: 31349971
[TBL] [Abstract][Full Text] [Related]
5. p38γ overexpression promotes osteosarcoma cell progression.
Shi C; Cheng WN; Wang Y; Li DZ; Zhou LN; Zhu YC; Zhou XZ
Aging (Albany NY); 2020 Sep; 12(18):18384-18395. PubMed ID: 32970611
[TBL] [Abstract][Full Text] [Related]
6. Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling.
Wang SS; Lv Y; Xu XC; Zuo Y; Song Y; Wu GP; Lu PH; Zhang ZQ; Chen MB
Cancer Lett; 2019 Feb; 443():13-24. PubMed ID: 30503558
[TBL] [Abstract][Full Text] [Related]
7. AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
Cao Q; Zhang J; Zhang T
Biomed Res Int; 2018; 2018():9253036. PubMed ID: 29854811
[TBL] [Abstract][Full Text] [Related]
8. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
9. Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells.
Niu Z; Liu H; Zhou M; Wang H; Liu Y; Li X; Xiong W; Ma J; Li X; Li G
Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):183-91. PubMed ID: 25630654
[TBL] [Abstract][Full Text] [Related]
10. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
11. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways.
Yang Y; Liao Q; Wei F; Li X; Zhang W; Fan S; Shi L; Li X; Gong Z; Ma J; Zhou M; Xiang J; Peng S; Xiang B; Deng H; Yang Y; Li Y; Xiong W; Zeng Z; Li G
PLoS One; 2013; 8(5):e62869. PubMed ID: 23650533
[TBL] [Abstract][Full Text] [Related]
12. ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.
Peng H; Zhang J; Zhang PP; Chen L; Tang LL; Yang XJ; He QM; Wen X; Sun Y; Liu N; Li YQ; Ma J
J Exp Clin Cancer Res; 2019 Jan; 38(1):11. PubMed ID: 30621723
[TBL] [Abstract][Full Text] [Related]
13. Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.
Xie P; Yang JP; Cao Y; Peng LX; Zheng LS; Sun R; Meng DF; Wang MY; Mei Y; Qiang YY; Cao L; Xiang YQ; Luo DH; Yun JP; Huang BJ; Jia LJ; Qian CN
Cell Death Dis; 2017 Jun; 8(6):e2834. PubMed ID: 28569775
[TBL] [Abstract][Full Text] [Related]
14. Effects of RNA interference targeting four different genes on the growth and proliferation of nasopharyngeal carcinoma CNE-2Z cells.
Song Y; Dong MM; Yang HF
Cancer Gene Ther; 2011 Apr; 18(4):297-304. PubMed ID: 21233856
[TBL] [Abstract][Full Text] [Related]
15. ADCK1 is a potential therapeutic target of osteosarcoma.
Zhuo BB; Zhu LQ; Yao C; Wang XH; Li SX; Wang R; Li Y; Ling ZY
Cell Death Dis; 2022 Nov; 13(11):954. PubMed ID: 36371387
[TBL] [Abstract][Full Text] [Related]
16. Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells.
Liu ZF; Yang J; Wei SP; Luo XG; Jiang QS; Chen T; Gong YQ
Kaohsiung J Med Sci; 2020 Nov; 36(11):895-903. PubMed ID: 32668092
[TBL] [Abstract][Full Text] [Related]
17. MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.
Chen C; Lu Z; Yang J; Hao W; Qin Y; Wang H; Xie C; Xie R
Cancer Med; 2016 Dec; 5(12):3489-3499. PubMed ID: 27774777
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
Liu N; He QM; Chen JW; Li YQ; Xu YF; Ren XY; Sun Y; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Ma J
Mol Cancer; 2014 May; 13():111. PubMed ID: 24884612
[TBL] [Abstract][Full Text] [Related]
19. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer.
Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T
Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Bmi-1 is associated with suppressed tumorigenesis and induced apoptosis in CD44⁺ nasopharyngeal carcinoma cancer stem-like cells.
Xu X; Liu Y; Su J; Li D; Hu J; Huang Q; Lu M; Liu X; Ren J; Chen W; Sun L
Oncol Rep; 2016 Feb; 35(2):923-31. PubMed ID: 26573774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
